NUProtein develops next-generation protein and bioactive compound production technologies using genetically engineered rice. By cultivating high-expression rice and extracting target components directly from the grain, the company achieves exceptionally low-cost and stable production compared with conventional methods. NUProtein is also recognized as one of the world’s five industrial players in cell-free protein synthesis and gene-related patents. Through low-cost growth factors and other functional proteins, the company is building a new supply chain for the cultivated meat and broader food-tech sectors.
A startup developing kidney disease treatments and cell therapies using iPS cell technology, expanding its achievements in the kidney disease field while advancing applications to the liver and pancreas.
We are developing technology to produce chemicals through microbial fermentation using renewable biomass resources as feedstock. Primarily targeting the apparel industry, we manufacture dyes and fiber raw materials via microbial fermentation, thereby contributing to reducing environmental impact. Additionally, we are actively pursuing new technological developments beyond microbial fermentation, aiming to supply environmentally conscious materials to the apparel industry by leveraging various technologies.
Bioaccell is a Kyoto-based contract cell processing company that cultivates therapeutic immune cells for medical institutions. It provides certified cell culture services for cancer immunotherapy.
A startup that synthesizes long, complex DNA using proprietary technology, enabling the flexible design of diverse gene combinations. It also provides comprehensive support from development to manufacturing processes for viral vectors and mRNA required for gene therapy.